BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10622426)

  • 21. Interactions of novel, nonhemolytic surfactants with phospholipid vesicles.
    Thorén PE; Söderman O; Engström S; von Corswant C
    Langmuir; 2007 Jun; 23(13):6956-65. PubMed ID: 17516668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Action of surface-active substances on biological membranes. IV. Hemolytic and membrane-perturbing action of homologous series of beta-D-glucopyranosyl-1-alkylphosphates.
    Zaslavsky BY; Ossipov NN; Rogozhin SV; Sebyakin L; Volkova LV; Evstigneeva RP
    Biochim Biophys Acta; 1979 Sep; 556(2):314-21. PubMed ID: 534630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemolysis by surfactants--A review.
    Manaargadoo-Catin M; Ali-Cherif A; Pougnas JL; Perrin C
    Adv Colloid Interface Sci; 2016 Feb; 228():1-16. PubMed ID: 26687805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of double-chained cationic surfactants n-dimethyldialkylammoniums on skin permeation of benzoic acid through excised guinea pig dorsal skin: comparison of their enhancement effects with hemolytic effects on erythrocytes.
    Kitagawa S; Kasamaki M; Hiyama F
    Chem Pharm Bull (Tokyo); 2001 Sep; 49(9):1155-8. PubMed ID: 11558602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolysis caused by polyoxyethylene-derived surfactants. Evidence for peroxide participation.
    Azaz E; Segal R; Milo-Goldzweig I
    Biochim Biophys Acta; 1981 Sep; 646(3):444-9. PubMed ID: 7284372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of New Antimicrobial Agents from Cationic PG-Surfactants Containing Oligo-Lys Peptides.
    Kimura R; Shibata M; Koeda S; Miyagawa A; Yamamura H; Mizuno T
    Bioconjug Chem; 2018 Dec; 29(12):4072-4082. PubMed ID: 30354128
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The hemolysis and solubilization behavior of nonionic polymer surface-active agents classes].
    Reinhart T; Bauer KH
    Pharmazie; 1995 Jun; 50(6):403-7. PubMed ID: 7544467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lysis of human red blood cells. 3: Effect of contact time on surfactant-induced hemolysis.
    Krzyzaniak JF; Yalkowsky SH
    PDA J Pharm Sci Technol; 1998; 52(2):66-9. PubMed ID: 9610170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitigation of surfactant erythrocyte toxicity by egg phosphatidylcholine.
    Gould LA; Lansley AB; Brown MB; Forbes B; Martin GP
    J Pharm Pharmacol; 2000 Oct; 52(10):1203-9. PubMed ID: 11092564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemolytic action of surface-active electrolytes.
    Kondo T; Tomizawa M
    J Colloid Interface Sci; 1966 Feb; 21(2):224-8. PubMed ID: 5906906
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of ionic head of cationic surface active agents on their hemolytic activity.
    Tomizawa M; Kondo T
    Chem Pharm Bull (Tokyo); 1970 Nov; 18(11):2158-63. PubMed ID: 5494848
    [No Abstract]   [Full Text] [Related]  

  • 32. Influence of various combinations of mucolytic agent and non-ionic surfactant on intestinal absorption of poorly absorbed hydrophilic compounds.
    Takatsuka S; Morita T; Horikiri Y; Yamahara H; Saji H
    Int J Pharm; 2008 Feb; 349(1-2):94-100. PubMed ID: 17869034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential irritation of lysine derivative surfactants by hemolysis and HaCaT cell viability.
    Sanchez L; Mitjans M; Infante MR; Vinardell MP
    Toxicol Lett; 2006 Feb; 161(1):53-60. PubMed ID: 16135402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemolytic activity of tensides--determination of the interaction between O/W- and W/O-surfactants].
    Friess W; Nürnberg E
    Pharmazie; 1994; 49(2-3):197-201. PubMed ID: 8171082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new physiologically approached in vitro test for quick evaluation of the hemolytic activity of surfactants.
    Stenz R; Bauer KH
    Pharmazie; 1996 May; 51(5):283-7. PubMed ID: 8710952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of new sugar-based surfactants and evaluation of their hemolytic activities.
    Neimert-Andersson K; Sauer S; Panknin O; Borg T; Söderlind E; Somfai P
    J Org Chem; 2006 Apr; 71(9):3623-6. PubMed ID: 16626152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The usefulness of sugar surfactants as solubilizing agents in parenteral formulations.
    Söderlind E; Wollbratt M; von Corswant C
    Int J Pharm; 2003 Feb; 252(1-2):61-71. PubMed ID: 12550781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the antimicrobial and hemolytic activities of amphiphilic beta-peptides.
    Arvidsson PI; Frackenpohl J; Ryder NS; Liechty B; Petersen F; Zimmermann H; Camenisch GP; Woessner R; Seebach D
    Chembiochem; 2001 Oct; 2(10):771-3. PubMed ID: 11948860
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of structural variations of non-ionic surfactants on surface properties: surfactants with semi-polar hydrophobes.
    Attwood D; Elworthy PH; Lawrence MJ
    J Pharm Pharmacol; 1990 Aug; 42(8):581-3. PubMed ID: 1981588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemolytic activity of maltopyranoside surfactants.
    Söderlind E; Karlsson L
    Eur J Pharm Biopharm; 2006 Apr; 62(3):254-9. PubMed ID: 16274978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.